Total Payments
$686.07
2024 Payments
$172.96
Companies
4
Transactions
37
Medicare Patients
1,199
Medicare Billing
$174,215
Payment Breakdown by Category
Food & Beverage$686.07 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $686.07 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $593.49 | 34 | $0 (2024) |
| Novo Nordisk Inc | $58.86 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.61 | 1 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $16.11 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172.96 | 9 | ABBVIE INC. ($172.96) |
| 2023 | $99.37 | 7 | ABBVIE INC. ($83.26) |
| 2022 | $190.53 | 10 | ABBVIE INC. ($172.92) |
| 2021 | $147.41 | 9 | AbbVie Inc. ($147.41) |
| 2020 | $16.94 | 1 | AbbVie Inc. ($16.94) |
| 2019 | $58.86 | 1 | Novo Nordisk Inc ($58.86) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: VIROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: VIROLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: VIROLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: VIROLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: VIROLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: VIROLOGY | ||||||
| 02/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: VIROLOGY | ||||||
| 02/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: VIROLOGY | ||||||
| 12/14/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: VIROLOGY | ||||||
| 10/18/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: VIROLOGY | ||||||
| 09/13/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: VIROLOGY | ||||||
| 07/12/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: VIROLOGY | ||||||
| 05/24/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: VIROLOGY | ||||||
| 03/07/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/02/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: VIROLOGY | ||||||
| 12/15/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: VIROLOGY | ||||||
| 11/30/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: VIROLOGY | ||||||
| 07/20/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: VIROLOGY | ||||||
| 05/25/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: VIROLOGY | ||||||
| 05/11/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: VIROLOGY | ||||||
| 05/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/23/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: VIROLOGY | ||||||
| 03/09/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: VIROLOGY | ||||||
| 02/23/2022 | ABBVIE INC. | VIEKIRA PAK (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 293 | 419 | $111,397 | $38,180 |
| 2022 | 7 | 284 | 482 | $107,780 | $45,160 |
| 2021 | 8 | 324 | 517 | $91,352 | $48,769 |
| 2020 | 9 | 298 | 467 | $82,024 | $42,106 |
Total Patients
1,199
Total Services
1,885
Medicare Billing
$174,215
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 117 | $31,319 | $10,632 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 86 | $20,487 | $8,217 | 40.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 50 | $25,874 | $6,415 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,357 | $3,403 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 23 | $7,713 | $3,100 | 40.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $6,961 | $2,649 | 38.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 38 | $7,075 | $2,272 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $2,863 | $1,130 | 39.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 44 | $748.00 | $362.04 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 104 | $28,190 | $13,831 | 49.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 163 | $35,340 | $13,152 | 37.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 36 | $13,567 | $5,361 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $10,376 | $4,833 | 46.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 64 | $9,638 | $3,606 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 25 | $6,757 | $2,754 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $3,129 | $1,488 | 47.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 33 | 46 | $782.00 | $136.05 | 17.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 59 | 163 | $26,080 | $13,987 | 53.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 62 | $19,530 | $10,284 | 52.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 54 | $13,230 | $7,609 | 57.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 56 | $9,520 | $5,685 | 59.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 80 | $9,200 | $4,872 | 53.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $6,720 | $3,110 | 46.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 17 | $6,035 | $3,041 | 50.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 40 | 61 | $1,037 | $181.73 | 17.5% |
About Dr. Amar Mahgoub, MD
Dr. Amar Mahgoub, MD is a Gastroenterology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609076355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amar Mahgoub, MD has received a total of $686.07 in payments from pharmaceutical and medical device companies, with $172.96 received in 2024. These payments were reported across 37 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($686.07).
As a Medicare-enrolled provider, Mahgoub has provided services to 1,199 Medicare beneficiaries, totaling 1,885 services with total Medicare billing of $174,215. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Transplant Hepatology
- Location Dallas, TX
- Active Since 07/20/2007
- Last Updated 09/27/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1609076355
Products in Payments
- MAVYRET (Drug) $572.50
- VIEKIRA PAK (Drug) $20.99
- GATTEX (Drug) $17.61
- ZENPEP (Drug) $16.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dallas
Dr. Michael Brown, Md, MD
Gastroenterology — Payments: $6.0M
Gastroenterology $6.0M
Jay Horton, Md, MD
Gastroenterology — Payments: $419,727
Gastroenterology $419,727
Dr. Lawrence Schiller, Md, MD
Gastroenterology — Payments: $380,832
Gastroenterology $380,832
Dr. Jacqueline O'leary, Md, Mph, MD, MPH
Gastroenterology — Payments: $338,210
Gastroenterology $338,210
Dr. Byron Cryer, M.d, M.D
Gastroenterology — Payments: $331,404
Gastroenterology $331,404
Dr. Sami Arslanlar, Md, MD
Gastroenterology — Payments: $144,674
Gastroenterology $144,674